286 related articles for article (PubMed ID: 33264139)
21. Neuroendocrine differentiation in a large series of genetically-confirmed Ewing's sarcoma family tumor: Does it provide any diagnostic or prognostic information?
Machado I; Navarro S; López-Guerrero JA; Verdini L; Picci P; Giner F; Llombart-Bosch A
Pathol Res Pract; 2021 Mar; 219():153362. PubMed ID: 33610950
[TBL] [Abstract][Full Text] [Related]
22. Syntaxin-1 and Insulinoma-Associated Protein 1 Expression in Breast Neoplasms with Neuroendocrine Features.
Turkevi-Nagy S; Báthori Á; Böcz J; Krenács L; Cserni G; Kővári B
Pathol Oncol Res; 2021; 27():1610039. PubMed ID: 34764822
[No Abstract] [Full Text] [Related]
23. A new immunohistochemical marker, insulinoma-associated protein 1 (INSM1), for Merkel cell carcinoma: Evaluation of 24 cases.
Leblebici C; Yeni B; Savli TC; Aydın Ö; Güneş P; Cinel L; Şimşek BÇ; Yıldız P; Tuncel D; Kayahan S
Ann Diagn Pathol; 2019 Jun; 40():53-58. PubMed ID: 31031215
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic Utility of INSM1 in Medullary Thyroid Carcinoma.
Seok JY; Kang M; De Peralta-Venturina M; Fan X
Int J Surg Pathol; 2021 Sep; 29(6):615-626. PubMed ID: 33650906
[TBL] [Abstract][Full Text] [Related]
25. INSM1 Is a Highly Specific Marker of Neuroendocrine Differentiation in Primary Neoplasms of the Gastrointestinal Tract, Appendix, and Pancreas.
McHugh KE; Mukhopadhyay S; Doxtader EE; Lanigan C; Allende DS
Am J Clin Pathol; 2020 May; 153(6):811-820. PubMed ID: 32128564
[TBL] [Abstract][Full Text] [Related]
26. A new marker, insulinoma-associated protein 1 (INSM1), for high-grade neuroendocrine carcinoma of the uterine cervix: Analysis of 37 cases.
Kuji S; Watanabe R; Sato Y; Iwata T; Hirashima Y; Takekuma M; Ito I; Abe M; Nagashio R; Omae K; Aoki D; Kameya T
Gynecol Oncol; 2017 Feb; 144(2):384-390. PubMed ID: 27908529
[TBL] [Abstract][Full Text] [Related]
27. Expression of neuroendocrine markers in non-neuroendocrine endometrial carcinomas.
Moritz AW; Schlumbrecht MP; Nadji M; Pinto A
Pathology; 2019 Jun; 51(4):369-374. PubMed ID: 31040050
[TBL] [Abstract][Full Text] [Related]
28. Exploration of INSM1 and hASH1 as additional markers in lung cytology samples of high-grade neuroendocrine carcinoma with indeterminate neuroendocrine differentiation.
Rothrock AT; Stewart J; Li F; Racila E; Amin K
Diagn Cytopathol; 2022 May; 50(5):230-234. PubMed ID: 35147301
[TBL] [Abstract][Full Text] [Related]
29. INSM1 immunostaining in solid papillary carcinoma of the breast.
Kudo N; Takano J; Kudoh S; Arima N; Ito T
Pathol Int; 2021 Jan; 71(1):51-59. PubMed ID: 33156579
[TBL] [Abstract][Full Text] [Related]
30. Insulinoma-associated protein 1 expression in primary and metastatic neuroendocrine neoplasms of the gastrointestinal and pancreaticobiliary tracts.
González I; Lu HC; Sninsky J; Yang C; Bishnupuri K; Dieckgraefe B; Cao D; Chatterjee D
Histopathology; 2019 Oct; 75(4):568-577. PubMed ID: 31077609
[TBL] [Abstract][Full Text] [Related]
31. Insulinoma-associated protein 1 is a robust nuclear immunostain for the diagnosis of small cell lung carcinoma in cytology smears.
Nakra T; Nambirajan A; Guleria P; Phulware RH; Jain D
Cancer Cytopathol; 2019 Aug; 127(8):539-548. PubMed ID: 31343851
[TBL] [Abstract][Full Text] [Related]
32. Musashi-1 Is a Novel Immunohistochemical Marker of Neuroendocrine Carcinoma of the Lung.
Izaki Y; Amatya VJ; Kambara T; Kushitani K; Miyata Y; Okada M; Takeshima Y
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067335
[TBL] [Abstract][Full Text] [Related]
33. Insulinoma-associated protein 1 (INSM1) expression in breast carcinomas with neuroendocrine morphologies: application and future prospective.
Kawasaki T; Kaira K
Virchows Arch; 2021 Jul; 479(1):191-194. PubMed ID: 33025295
[TBL] [Abstract][Full Text] [Related]
34. Expression of Insulinoma-Associated Protein 1 (INSM1) and Orthopedia Homeobox (OTP) in Tumors with Neuroendocrine Differentiation at Rare Sites.
Roy M; Buehler DG; Zhang R; Schwalbe ML; Baus RM; Salamat MS; Lloyd RV; Rosenbaum JN
Endocr Pathol; 2019 Mar; 30(1):35-42. PubMed ID: 30523500
[TBL] [Abstract][Full Text] [Related]
35. Insulinoma-associated protein 1 is a novel sensitive and specific marker for small cell carcinoma of the prostate.
Xin Z; Zhang Y; Jiang Z; Zhao L; Fan L; Wang Y; Xie S; Shangguan X; Zhu Y; Pan J; Liu Q; Huang Y; Dong B; Xue W
Hum Pathol; 2018 Sep; 79():151-159. PubMed ID: 29885405
[TBL] [Abstract][Full Text] [Related]
36. Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samples.
Kriegsmann K; Zgorzelski C; Muley T; Christopoulos P; Thomas M; Winter H; Eichhorn M; Eichhorn F; von Winterfeld M; Herpel E; Goeppert B; Stenzinger A; Herth FJF; Warth A; Kriegsmann M
BMC Cancer; 2021 May; 21(1):486. PubMed ID: 33933015
[TBL] [Abstract][Full Text] [Related]
37. INSM1 Is More Sensitive and Interpretable than Conventional Immunohistochemical Stains Used to Diagnose Merkel Cell Carcinoma.
Lilo MT; Chen Y; LeBlanc RE
Am J Surg Pathol; 2018 Nov; 42(11):1541-1548. PubMed ID: 30080705
[TBL] [Abstract][Full Text] [Related]
38. Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor.
Tanigawa M; Nakayama M; Taira T; Hattori S; Mihara Y; Kondo R; Kusano H; Nakamura K; Abe Y; Ishida Y; Okabe Y; Hisaka T; Okuda K; Fujino K; Ito T; Kawahara A; Naito Y; Yamaguchi R; Akiba J; Akagi Y; Yano H
Med Mol Morphol; 2018 Mar; 51(1):32-40. PubMed ID: 28849340
[TBL] [Abstract][Full Text] [Related]
39. INSM1 expression in primary and metastatic neuroendocrine neoplasms at distinct locations.
Wang XQ; Fu J; Zhang YT; Xu Y
Pathol Res Pract; 2024 Jan; 253():155067. PubMed ID: 38171081
[TBL] [Abstract][Full Text] [Related]
40. Insulinoma-associated protein 1 immunostaining for various types of neuroendocrine tumors on FNA smears.
Hou T; Gan Q; Joseph CT; Sun X; Gong Y
Cancer Cytopathol; 2020 Oct; 128(10):725-732. PubMed ID: 32573984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
